[The correlation of lipid profile and serum osmolality with kidney progression in patients with type 2 diabetes mellitus].

<b>Objective:</b> To investigate the correlation of lipid profile and serum osmolality (OsP) with kidney progression in patients with type 2 diabetes mellitus (T2DM). <b>Methods:</b> A nested case-control study was conducted. Inpatients with T2DM who visited Guizhou Provincial People's Hospital in 2019 were included. Demographic characteristics, laboratory indices, and kidney progression events were collected. The correlation of lipid profile and OsP with kidney progression in T2DM were analyzed using multivariable Cox proportional hazards regression models and causal mediation analysis. <b>Results:</b> A total of 1 219 patients (714 males and 505 females) were included, aged (59.7±14.6) years. The median (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) follow-up duration was 54 (51, 58) months, with a loss to follow-up rate of 11.9% (145/1 219). Kidney progression occurred in 21.3% (260/1 219) of the patients. Cox proportional hazards regression analysis revealed that elevated OsP (<i>HR</i>=1.02, 95%<i>CI</i>: 1.01-1.02, <i>P</i><0.001), remnant cholesterol (RC) (<i>HR</i>=1.12, 95%<i>CI</i>: 1.02-1.23, <i>P</i>=0.023), apolipoprotein B (ApoB) (<i>HR</i>=1.59, 95%<i>CI</i>: 1.02-2.46, <i>P</i>=0.040), and age (<i>HR</i>=1.02, 95%<i>CI</i>: 1.01-1.03, <i>P</i><0.001) were identified as risk factors for kidney progression in T2DM. Compared with OsP<310 mmol/L, patients with OsP≥310 mmol/L had a significantly increased risk of kidney progression (<i>HR</i>=1.94, 95%<i>CI</i>: 1.50-2.51, <i>P</i><0.001). Causal mediation analysis using bootstrap resampling (N=5 000) indicated that RC and ApoB mediated 3.39% (95%<i>CI</i>: 0.98%-5.00%, <i>P</i>=0.020) and 9.54% (95%<i>CI</i>: 8.28%-17.00%, <i>P</i>=0.048) of the effect of OsP on kidney progression, respectively. <b>Conclusion:</b> Elevated OsP level in T2DM patients is a risk factor for kidney progression, with RC and ApoB mediating the effect of OsP on kidney progression in T2DM.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-03-25
DOI
https://doi.org/10.3760/cma.j.cn112137-20241111-02522
Primary Topic
Neurological and metabolic disorders
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[The correlation of lipid profile and serum osmolality with kidney progression in patients with type 2 diabetes mellitus].

Yan Zha, Rong Dong, Jing Yuan, Q Li et al.
PubMed
Neurological and metabolic disorders
article

[The correlation of lipid profile and serum osmolality with kidney progression in patients with type 2 diabetes mellitus].

Yan Zha, Rong Dong, Jing Yuan, Q Li, Jingjing Da, Yuqi Yang, Jing Luo
article en

Abstract

<b>Objective:</b> To investigate the correlation of lipid profile and serum osmolality (OsP) with kidney progression in patients with type 2 diabetes mellitus (T2DM). <b>Methods:</b> A nested case-control study was conducted. Inpatients with T2DM who visited Guizhou Provincial People's Hospital in 2019 were included. Demographic characteristics, laboratory indices, and kidney progression events were collected. The correlation of lipid profile and OsP with kidney progression in T2DM were analyzed using multivariable Cox proportional hazards regression models and causal mediation analysis. <b>Results:</b> A total of 1 219 patients (714 males and 505 females) were included, aged (59.7±14.6) years. The median (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) follow-up duration was 54 (51, 58) months, with a loss to follow-up rate of 11.9% (145/1 219). Kidney progression occurred in 21.3% (260/1 219) of the patients. Cox proportional hazards regression analysis revealed that elevated OsP (<i>HR</i>=1.02, 95%<i>CI</i>: 1.01-1.02, <i>P</i><0.001), remnant cholesterol (RC) (<i>HR</i>=1.12, 95%<i>CI</i>: 1.02-1.23, <i>P</i>=0.023), apolipoprotein B (ApoB) (<i>HR</i>=1.59, 95%<i>CI</i>: 1.02-2.46, <i>P</i>=0.040), and age (<i>HR</i>=1.02, 95%<i>CI</i>: 1.01-1.03, <i>P</i><0.001) were identified as risk factors for kidney progression in T2DM. Compared with OsP<310 mmol/L, patients with OsP≥310 mmol/L had a significantly increased risk of kidney progression (<i>HR</i>=1.94, 95%<i>CI</i>: 1.50-2.51, <i>P</i><0.001). Causal mediation analysis using bootstrap resampling (N=5 000) indicated that RC and ApoB mediated 3.39% (95%<i>CI</i>: 0.98%-5.00%, <i>P</i>=0.020) and 9.54% (95%<i>CI</i>: 8.28%-17.00%, <i>P</i>=0.048) of the effect of OsP on kidney progression, respectively. <b>Conclusion:</b> Elevated OsP level in T2DM patients is a risk factor for kidney progression, with RC and ApoB mediating the effect of OsP on kidney progression in T2DM.

PubMedVol. 105(12)
Guizhou Provincial People's Hospital (CN)
Neurological and metabolic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.